395 related articles for article (PubMed ID: 29636993)
1. Circulating biomarkers for early diagnosis of pancreatic cancer: facts and hopes.
Zhang X; Shi S; Zhang B; Ni Q; Yu X; Xu J
Am J Cancer Res; 2018; 8(3):332-353. PubMed ID: 29636993
[TBL] [Abstract][Full Text] [Related]
2. Pancreatic Cancer Diagnosis and Management: Has the Time Come to Prick the Bubble?
Moutinho-Ribeiro P; Macedo G; Melo SA
Front Endocrinol (Lausanne); 2018; 9():779. PubMed ID: 30671023
[TBL] [Abstract][Full Text] [Related]
3. Early detection of pancreatic cancer: Where are we now and where are we going?
Zhou B; Xu JW; Cheng YG; Gao JY; Hu SY; Wang L; Zhan HX
Int J Cancer; 2017 Jul; 141(2):231-241. PubMed ID: 28240774
[TBL] [Abstract][Full Text] [Related]
4. Circulating microRNAs as promising diagnostic biomarkers for pancreatic cancer: a systematic review.
Xue J; Jia E; Ren N; Lindsay A; Yu H
Onco Targets Ther; 2019; 12():6665-6684. PubMed ID: 31692495
[TBL] [Abstract][Full Text] [Related]
5. Circulating RNAs as new biomarkers for detecting pancreatic cancer.
Kishikawa T; Otsuka M; Ohno M; Yoshikawa T; Takata A; Koike K
World J Gastroenterol; 2015 Jul; 21(28):8527-40. PubMed ID: 26229396
[TBL] [Abstract][Full Text] [Related]
6. Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers' Discovery.
Brancaccio M; Natale F; Falco G; Angrisano T
Genes (Basel); 2019 Dec; 11(1):. PubMed ID: 31877923
[TBL] [Abstract][Full Text] [Related]
7. Use of Biomarkers and Imaging for Early Detection of Pancreatic Cancer.
Kato S; Honda K
Cancers (Basel); 2020 Jul; 12(7):. PubMed ID: 32707720
[TBL] [Abstract][Full Text] [Related]
8. Progress and potential of exosome analysis for early pancreatic cancer detection.
Erb U; Zöller M
Expert Rev Mol Diagn; 2016 Jul; 16(7):757-67. PubMed ID: 27206554
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNAs as biomarkers for early diagnosis of coronary artery disease.
Zhang L; Zhang Y; Zhao Y; Wang Y; Ding H; Xue S; Li P
Expert Opin Ther Pat; 2018 Aug; 28(8):591-601. PubMed ID: 30064285
[TBL] [Abstract][Full Text] [Related]
10. Non-invasive biomarkers in pancreatic cancer diagnosis: what we need versus what we have.
Herreros-Villanueva M; Bujanda L
Ann Transl Med; 2016 Apr; 4(7):134. PubMed ID: 27162784
[TBL] [Abstract][Full Text] [Related]
11. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples.
Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L
Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738
[TBL] [Abstract][Full Text] [Related]
12. A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer.
Shinjo K; Hara K; Nagae G; Umeda T; Katsushima K; Suzuki M; Murofushi Y; Umezu Y; Takeuchi I; Takahashi S; Okuno Y; Matsuo K; Ito H; Tajima S; Aburatani H; Yamao K; Kondo Y
PLoS One; 2020; 15(6):e0233782. PubMed ID: 32520974
[TBL] [Abstract][Full Text] [Related]
13. Circulating Tumor Cells and Cell-Free DNA in Pancreatic Ductal Adenocarcinoma.
Gall TMH; Belete S; Khanderia E; Frampton AE; Jiao LR
Am J Pathol; 2019 Jan; 189(1):71-81. PubMed ID: 30558725
[TBL] [Abstract][Full Text] [Related]
14. Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.
Earl J; Garcia-Nieto S; Martinez-Avila JC; Montans J; Sanjuanbenito A; Rodríguez-Garrote M; Lisa E; Mendía E; Lobo E; Malats N; Carrato A; Guillen-Ponce C
BMC Cancer; 2015 Oct; 15():797. PubMed ID: 26498594
[TBL] [Abstract][Full Text] [Related]
15. Circulating MicroRNAs: Valuable Biomarkers for the Diagnosis and Prognosis of Gastric Cancer.
Shekari N; Baradaran B; Shanehbandi D; Kazemi T
Curr Med Chem; 2018 Feb; 25(6):698-714. PubMed ID: 28971758
[TBL] [Abstract][Full Text] [Related]
16. What's new in the diagnosis of pancreatic cancer: a patent review (2011-present).
Boulaiz H; Ramos MC; Griñán-Lisón C; García-Rubiño ME; Vicente F; Marchal JA
Expert Opin Ther Pat; 2017 Dec; 27(12):1319-1328. PubMed ID: 28929814
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic significance assessment of the circulating cell-free DNA in ovarian cancer: An updated meta-analysis.
Li B; Pu K; Ge L; Wu X
Gene; 2019 Sep; 714():143993. PubMed ID: 31330238
[TBL] [Abstract][Full Text] [Related]
18. Clinical Applications of Circulating Tumour DNA in Pancreatic Adenocarcinoma.
Loft M; Lee B; Tie J; Gibbs P
J Pers Med; 2019 Jul; 9(3):. PubMed ID: 31323810
[TBL] [Abstract][Full Text] [Related]
19. Liquid biopsy in patients with pancreatic cancer: Circulating tumor cells and cell-free nucleic acids.
Imamura T; Komatsu S; Ichikawa D; Kawaguchi T; Miyamae M; Okajima W; Ohashi T; Arita T; Konishi H; Shiozaki A; Morimura R; Ikoma H; Okamoto K; Otsuji E
World J Gastroenterol; 2016 Jul; 22(25):5627-41. PubMed ID: 27433079
[TBL] [Abstract][Full Text] [Related]
20. Recent advances in gastric cancer early diagnosis.
Necula L; Matei L; Dragu D; Neagu AI; Mambet C; Nedeianu S; Bleotu C; Diaconu CC; Chivu-Economescu M
World J Gastroenterol; 2019 May; 25(17):2029-2044. PubMed ID: 31114131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
